| Literature DB >> 26184176 |
Nur Farhana Ahmad Sopian1, Mokrish Ajat2, Nurul' Izzati Shafie1, Mohd Hezmee Mohd Noor3, Mehdi Ebrahimi4, Mohamed Ali Rajion5, Goh Yong Meng6, Hafandi Ahmad7.
Abstract
Dietary omega-3 fatty acids have been recognized to improve brain cognitive function. Deficiency leads to dysfunctional zinc metabolism associated with learning and memory impairment. The objective of this study is to explore the effect of short-term dietary omega-3 fatty acids on hippocampus gene expression at the molecular level in relation to spatial recognition memory in mice. A total of 24 male BALB/c mice were randomly divided into four groups and fed a standard pellet as a control group (CTL, n = 6), standard pellet added with 10% (w/w) fish oil (FO, n = 6), 10% (w/w) soybean oil (SO, n = 6) and 10% (w/w) butter (BT, n = 6). After 3 weeks on the treatment diets, spatial-recognition memory was tested on a Y-maze. The hippocampus gene expression was determined using a real-time PCR. The results showed that 3 weeks of dietary omega-3 fatty acid supplementation improved cognitive performance along with the up-regulation of α-synuclein, calmodulin and transthyretin genes expression. In addition, dietary omega-3 fatty acid deficiency increased the level of ZnT3 gene and subsequently reduced cognitive performance in mice. These results indicate that the increased the ZnT3 levels caused by the deficiency of omega-3 fatty acids produced an abnormal zinc metabolism that in turn impaired the brain cognitive performance in mice.Entities:
Keywords: ZnT3; brain gene expression; cognitive function; omega-3 fatty acid
Mesh:
Substances:
Year: 2015 PMID: 26184176 PMCID: PMC4519926 DOI: 10.3390/ijms160715800
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Expression of α-synuclein, transthyretin, calmodulin and ZnT3 in the brain hippocampus of treatment groups compared to the CTL group. Results are normalized to the expression of GAPDH and β-actin. Treated samples were expressed relative to gene expression of the CTL group. Statistical analysis was performed using the Student’s t-test. Values indicated by * show significant differences compared with the CTL group at p < 0.05. FO, fish oil; SO, soybean oil; BT, butter; CTL, control.
Fatty acid profile (% of total identified fatty acids) of the brain hippocampus.
| Treatments | FO | SO | BT | CTRL | SEM |
|---|---|---|---|---|---|
| C16:0 (Palmitic acid) | 32.43 | 32.48 | 34.27 | 32.89 | 0.69 |
| C16:1n-7 (Palmitoleic acid) | 1.01 | 0.77 | 1.21 | 1.11 | 0.15 |
| C18:0 (Stearic acid) | 7.36 | 7.96 | 7.63 | 7.66 | 0.29 |
| C18:1n-9 (Oleic acid) | 29.09 b | 29.84 b | 29.86 b | 33.46 a | 0.75 |
| C18:2n-6 (Linoleic acid) | 5.72 | 5.55 | 5.82 | 6.44 | 0.16 |
| C18:3n-6 (Linolenic acid) | 0.83 | 0.99 | 0.77 | 0.75 | 0.06 |
| C18:3n-3 (α-linolenic acid) | 0.76 | 1.00 | 1.18 | 0.42 | 0.23 |
| C20:1n-9 (Arachidic acid) | 1.99 | 2.03 | 1.29 | 0.87 | 0.19 |
| C20:4n-6 (Arachidonic acid) | 1.03 | 1.03 | 1.29 | 1.36 | 0.12 |
| C20:5n-3 (Eicoapentaenoic acid) | 1.03 | 1.05 | 1.33 | 0.45 | 0.21 |
| C22:4n-6 (Docosatetraenoic acid) | 3.02 | 3.72 | 3.12 | 3.03 | 0.15 |
| C22:5n-3 (Docosapentaenoic acid) | 1.25 | 1.04 | 1.78 | 1.61 | 0.27 |
| C22:6n-3 (Docosahexaenoic acid) | 14.47 a | 12.55 ab | 10.44 b | 9.95 b | 0.73 |
| TOTAL SFA | 39.79 | 40.43 | 41.90 | 40.55 | 0.67 |
| TOTAL MUFA | 35.11 | 36.37 | 35.49 | 38.47 | 0.59 |
| TOTAL n-6 PUFA | 10.60 | 11.28 | 10.99 | 11.57 | 0.23 |
| TOTAL n-3 PUFA | 17.51 a | 15.64 ab | 14.74 ab | 12.44 b | 1.07 |
| n-6:n-3 Ratio | 0.63 b | 0.72 b | 0.84 ab | 0.93 a | 0.06 |
a,b Different alphabets in the same row denote significant difference at p < 0.005. FO, fish oil; SO, soybean oil; BT, butter; CTL, control; SEM, standard error of the mean; SFA, saturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.
Figure 2The potential molecular mechanism by which omega-3 fatty acid may interact with the zinc transporter in brain cognitive function.